Please assess the completion status of the following clinical trial:

Trial Title: Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients aged between 0 and 21 years with relapsed or refractary acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma.~* Lansky Index \> 60%.~* Left ventricular ejection fraction \> 39%.~* Negative HIV serology.~* Provide informed consent in accordance with current legislation.~Exclusion Criteria:~* Patients with a history of poor compliance.~* Patients not valid after psycho-social evaluation~* Severe (4) functional organ disorders (hepatic, renal, respiratory) according to NCI CTCAE v3 criteria

- Gender: ALL
- Minimum Age: None
- Maximum Age: 21 Years
- Healthy Volunteers: f

Study Arms:
- Activated natural killer cells (Type: EXPERIMENTAL): Activated natural killer cells

Based on this trial design, predict the completion outcome and termination type (if applicable).